An Enhancing Effect of Poly-Lysine on the Activation of Plasminogen

Summary

This study demonstrates that poly-lysine mimics the cofactor (enhancing) function of fibrin that is seen in tissue activator-induced plasminogen activation. Additionally, and in contrast to fibrin, poly-lysine exhibited an enhancing effect on low molecular weight (and not high molecular weight) urokinase-induced plasminogen activation.

A mechanism is proposed for this enhancement that involves the rendezvous and local concentration of plasminogen and plasminogen activator molecules on the lysine polymer. All components were able to bind to immobilized poly-lysine making the proposed machanism feasible. It was possible to elute the activators and mini-plasminogen by high salt (1 M NaCl), in contrast to Glu-plasminogen and plasmin which required 1 M lysine for elution, suggesting specific binding involving lysine binding sites.

The enhancing effect was specific for poly-D- and L-lysine and poly-L-ornithine, which has a similar structure. The use of poly-lysine can lead to a better standardization and increased sensitivity of indirect two-step assays for plasminogen activators employing synthetic chromogenic substrates.

Key words

Plasminogen activation - Urokinase - Tissue plasminogen activator - Poly-lysine - Enhancement of plasminogen activation - Plasminogen activator assay - Lysine binding site

• References

• 1 Wallén P. Chemistry of plasminogen and plasminogen activation. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers CC. (Eds). Raven Press; Vol 3 167-181 New York: 1978
• 2 Camiolo SM, Thorsen S, Astrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin and plasmin. Proc Soc Exptl Biol Med 1971; 38: 277-280
• 3 Rijken DC, Wijngaards G, Welbergen J. Immunological characterization of plasminogen activator activities in human tissues and body fluids. J Lab Clin Med 1981; 97: 477-486
• 4 Thorsen S, Glas-Greenwalt P, Astrup T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombos Diathes Haemorrh 1972; 28: 65-74
• 5 Allen RA, Pepper DS. Isolation and properties of human vascular plasminogen activator. Thromb Haemostas 1981; 45: 43-50
• 6 Imanari T, Wilcox GM, Pisano JJ. Sensitive radiochemical esterolytic assays for urokinase. Clin Chim Acta 1976; 71: 267-276
• 7 Bigbee WL, Weintraub HB, Jensen RH. Sensitive fluorescence assays for urokinase using synthetic peptide 4-methoxy-β-naphthylamide substrates. Anal Biochem 1978; 88: 114-122
• 8 Drapier JC, Tenu JP, Lemaire G, Petit JF. Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. Role of serum studied by a new spectrophotometric assay for plasminogen activators. Biochemie 1979; 61: 463-471
• 9 Liu H-Y, Peltz GA, Leytus SP, Livingston C, Brocklehurst J, Mangel WF. Sensitive assay for plasminogen activator of transformed cells. Proc Natl Acad Sci USA 1980; 77: 3796-3800
• 10 Pepper DS, Allen RA. Isolation and characterization of human cadaver vascular endothelial activator. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (Eds) Raven Press; Vol 3 91-98 New York: 1978
• 11 Allen RA. Studies on the human vascular plasminogen activator. Cell Biol Intern Reports 1980; 4: 803
• 12 Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemostas 1980; 43: 77-89
• 13 Cederholm-Williams SA. The binding of fibrinolytic enzymes to fibrin. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JE, Cêpelàk V, Samama MM, Desnoyers PC. (Eds). Churchill Livingstone; Vol 4 -32 38 Edinburgh: 1979
• 14 Rijken DC, Wijngaards G, Zaal-de JongM, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 1979; 580: 140-153
• 15 Winn ES, Hu SP, Hochschwender SM, Laursen RA. Studies on the lysine-binding sites of human plasminogen. The effect of ligand structure on the binding of lysine analogues to plasminogen. Eur J Biochem 1980; 104: 579-586
• 16 Claeys H, Vermylen J. Physico-chemical and pro-enzyme properties of NH₂-terminal glutamic acid and NH₂-terminal lysine human plasminogen. Biochim Biophys Acta 1974; 342: 351-359
• 17 Thorsen S, Müllertz S. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. J Clin Lab Invest 1974; 34: 167-176
• 18 Walther PJ, Hill RL, McKee PA. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. J Biol Chem 1975; 250: 5926-5933
• 19 Allen RA. The effect of poly-lysine on the activation of plasminogen. In: Progress in Fibrinolysis. Previously Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Nilsson IM, Astedt B. (Eds). Churchill Livingstone; Vol 5 134-138 Edinburgh: 1981
• 20 Hecht E. Studien über den lipoiden Aktivator der Blutgerinnung. Thrombos Diathes Haemorrh 1957; 1: 380-396
• 21 Dahl R, Venge P. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb Res 1979; 14: 599-608
• 22 Kluft C. Quantitation and behaviour of extrinsic or vascular plasminogen activator in blood. In: Progress in Fibrinolysis. Previously Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Nilsson IM, Asted B. (Eds). Vol 5 24-30 Churchill Livingstone; Edinburgh: 1981